HR 1548, the "Leveling the Playing Field 2.0 Act," amends U.S. trade laws to strengthen enforcement of antidumping and countervailing duty regulations. The bill creates new rules for handling multiple investigations on the same merchandise (successive investigations), addresses market distortions in foreign countries that affect production costs, and improves mechanisms to prevent companies from circumventing existing duties. It also establishes procedures for investigating currency undervaluation as a form of subsidy and strengthens requirements for importers to certify compliance with trade laws. These changes primarily affect U.S. importers of foreign goods, foreign exporters, and the Department of Commerce, which administers these trade enforcement mechanisms.
Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act or the PREVENT DIABETES Act This bill allows health care entities to provide virtual services under the Medicare Diabetes Prevention Program for an additional three years. The Medicare Diabetes Prevention Program offers Medicare beneficiaries who are at risk of developing Type 2 diabetes specialized training and education regarding diet, exercise, and other behavioral changes. The Centers for Medicare & Medicaid Services issued temporary authorization for entities participating in the program to provide these services virtually until December 31, 2027. The bill extends the authorization for virtual services until December 31, 2030.
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be program-certified in order to dispense mifepristone. The modifications allow certified retail pharmacies to dispense mifepristone pursuant to prescriptions that are written by certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
HR 1539, the Medical Device Electronic Labeling Act, allows medical device manufacturers to provide required product labeling exclusively through electronic means, rather than physical copies. This change directly affects device manufacturers, healthcare providers, and patients who access device information. Key provisions require that electronic labeling be readily accessible online, manufacturers must provide paper copies upon request without cost, and the physical device label must still include essential safety and usage information. The bill does not alter existing safety standards but updates how labeling is delivered, with the FDA retaining authority to issue additional requirements via Federal Register notices for specific devices.
The American Victims of Terrorism Compensation Act amends the Justice for United States Victims of State Sponsored Terrorism Act to increase funding for victims of terrorism. It directs the transfer of approximately $1.5 billion from the Binance Holdings Limited case, plus 50% of excess unobligated balances from Department of Justice and Treasury forfeiture funds, into the Victims Fund. The bill establishes deadlines for agencies to deposit funds (within 30 days of receipt or 15 days after enactment), requires annual reports on fund activity, and authorizes annual payments to eligible claimants starting in 2026. This legislation directly affects terrorism victims who receive compensation from the fund and federal agencies that handle forfeited assets from terrorism-related cases.
HR 1524, the ALYSSA Act, requires all public elementary and secondary schools receiving federal education funds to install silent panic alarms. The bill amends the Elementary and Secondary Education Act to mandate that each school must have at least one silent alarm system for security emergencies like active shooters or lockdowns. These alarms must generate a silent signal to law enforcement without alerting the threat, defined as a device manually activated for life-threatening situations. The requirement applies to all schools served by local educational agencies as a condition for receiving federal funds under the ESEA.
HRES 148 is a non-binding resolution expressing the House's view that China misrepresents UN Resolution 2758 (1971) as endorsing its "One China Principle" (claiming Taiwan is part of China), when the resolution only addressed which government represented China at the UN. It clarifies that the U.S. "One China Policy" does not accept China's claim over Taiwan and affirms the U.S. stance that Taiwan's status should be resolved peacefully by the people on both sides of the strait. The resolution opposes China's use of this misrepresentation to pressure other nations to sever ties with Taiwan and block Taiwan's participation in international organizations like the WHO or UN agencies. It specifically urges the U.S. to support Taiwan's meaningful engagement in international bodies and ensure Taiwan passport holders can access UN facilities without requiring Chinese-issued permits. The resolution aims to correct China's "false narratives" about Resolution 2758's meaning, not to change U.S. policy.
HR 1502 authorizes the creation of a Congressional Gold Medal to honor the volunteers and communities (primarily from Nebraska, Colorado, and Kansas) who supported the North Platte Canteen during World War II. The bill directs the Treasury Secretary to design and strike the medal, which will be presented to the individuals who contributed to the canteen’s operations and then permanently displayed at the Lincoln County Historical Museum in North Platte, Nebraska. It also permits the sale of bronze duplicates to cover production costs, with proceeds going to the U.S. Mint. This is a commemorative measure recognizing historical service, not a policy change affecting current laws or programs.
HR 1475, the SBA Disaster Transparency Act, requires the Small Business Administration (SBA) to publish all disaster assistance reports on its website. This bill amends existing law by adding specific language mandating that the SBA "publish on the website of the Administration" reports related to disaster assistance, including those submitted by state and local officials. The key mechanism is a procedural update to existing reporting requirements, ensuring all required reports are publicly accessible online rather than only being submitted internally. This directly affects the SBA (by changing its reporting process) and the public (by providing greater transparency into how disaster aid is distributed). The bill does not alter disaster assistance eligibility or funding levels.
HR 1492 amends the Social Security Act to extend the negotiation period for standard drug manufacturers under the federal drug pricing program. Specifically, it changes the timeframe from 7 years to 11 years for small-molecule drugs (like traditional pills) to negotiate prices with the government, aligning it with the existing 12-year period for complex biologic drugs (like insulin or monoclonal antibodies). This adjustment directly affects pharmaceutical companies that produce small-molecule drugs, giving them a longer window to negotiate pricing terms. The bill makes this change effective as if it had been part of the 2022 law that established the program.
This bill would require states to create a simplified process for out-of-state healthcare providers to join Medicaid and CHIP programs. Qualified providers (those already enrolled in Medicare or another state's program with low fraud risk) could enroll without excessive screening and would be approved for five years. It directly affects children under 21 enrolled in Medicaid or CHIP by expanding access to providers outside their state, particularly in underserved areas. The change applies to all states' Medicaid programs but takes effect three years after enactment.
HR 1500 requires federal agencies to prioritize native plants over non-native plants in landscaping projects at federal facilities (like military bases, parks, and government buildings), where feasible considering cost and maintenance. It mandates agencies to update design standards within 270 days, include native plant requirements in contracts, and consider benefits like supporting pollinators and reducing water use. Agencies must also report annually on implementation, including case studies and environmental impacts, starting two years after the law takes effect. This affects all federal projects involving landscape improvements across all states and territories.
